Skip to main content

Combinatorial Drug Discovery from Activity-Related Substructure Identification

  • Chapter
  • First Online:
Structural Bioinformatics: Applications in Preclinical Drug Discovery Process

Abstract

A newly developed drug discovery method composed of graph theoretical approaches for generating structures combinatorially from an activity-related root vertex, prediction of activity using topological distance-based vertex index and a rule-based algorithm and prioritization of putative active compounds using a newly defined Molecular Priority Score (MPS) has been described in this chapter. The rule-based method is also used for identifying suitable activity-related vertices (atoms) present in the active compounds of a data set, and identified vertex is used for combinatorial generation of structures. An algorithm has also been described for identifying suitable training set–test set splits (combinations) for a given data set since getting a suitable training set is of utmost importance for getting acceptable activity prediction. The method has also been used, to our knowledge for the first time, for matching and searching rooted trees and sub-trees in the compounds of a data set to discover novel drug candidates. The performance of different modules of the proposed method has been investigated by considering two different series of bioactive compounds: (1) convulsant and anticonvulsant barbiturates and (2) nucleoside analogues with their activities against HIV and a data set of 3779 potential antitubercular compounds. While activity prediction, compound prioritization and structure generation studies have been carried out for barbiturates and nucleoside analogues , activity-related tree–sub-tree searching in the said data set has been carried for screening potential antitubercular compounds. All the results show a high level of success rate. The possible relation of this work with scaffold hopping and inverse quantitative structure–activity relationship (iQSAR) problem has also been discussed. This newly developed method seems to hold promise for discovering novel therapeutic candidates.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

QSAR:

Quantitative structure–activity relationship

iQSAR:

Inverse quantitative structure–activity relationship

vHTS:

Virtual high-throughput screening

MIC:

Minimum inhibitory concentration

Mtb:

Mycobacterium tuberculosis

AAE:

Acid alkyl ester

NA:

Nucleoside analogue

HIV:

Human immunodeficiency virus

MPS:

Molecular Priority Score

ARL:

Active range length

ARW:

Active range weight

ARV:

Active range value

MAI:

Molecular activity index

IRL:

Inactive range length

IRW:

Inactive range weight

IRV:

Inactive range value

MDI:

Molecular de-activity index

SMILES:

Simplified molecular-input line-entry system

MOL file:

Molecular structural information file

References

  1. Ruddigkeit L, Van deursen R, Blum LC, Reymond JL (2012) Enumeration of 166 billion organic small molecules in the chemical universe database GDB-17. J Chem Inf Model 52:2864–2875

    Article  CAS  Google Scholar 

  2. Hansch C, Sammes PG, Taylor JB, Ramsden C (1990) Comprehensive medicinal chemistry: quantitative drug design, vol 4. Pergamon Press

    Google Scholar 

  3. Kier LB, Hall LH (1986) Molecular connectivity in structure-activity analysis. Research Studies Press

    Google Scholar 

  4. Stuper AJ, Brügger WE, Jurs PC (1979) Computer assisted studies of chemical structure and biological function. Wiley

    Google Scholar 

  5. Kitchen DB, Decornez H, Furr JR, Bajorath J (2004) Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov 3:935–949

    Article  CAS  Google Scholar 

  6. Cramer RD (2003) Topomer CoMFA: a design methodology for rapid lead optimization. J Med Chem 46:374–389

    Article  CAS  Google Scholar 

  7. Sun H, Tawa G, Wallqvist A (2012) Classification of scaffold-hopping approaches. Drug Discovery Today 17:310–324

    Article  CAS  Google Scholar 

  8. Tanwar J, Das S, Fatima Z, Hameed S (2014) Multidrug resistance: an emerging crisis. Interdiscip Perspect Infect Dis 2014

    Google Scholar 

  9. Gálvez J, García-Domenech R (2010) On the contribution of molecular topology to drug design and discovery. Curr Comput Aided Drug Des 6:252–268

    Article  Google Scholar 

  10. Gugisch R, Kerber A, Kohnert A, Laue R, Meringer M, Rücker C, Wassermann A (2014) MOLGEN 5.0, a molecular structure generator. In: Advances in mathematical chemistry and applications, vol 1. Bentham Publishers, pp 113–138

    Google Scholar 

  11. Harary F (1972) Graph theory. Addison-Wesley

    Google Scholar 

  12. Faulon JL, Bender A (2010) Handbook of chemoinformatics algorithms. CRC press

    Google Scholar 

  13. Wong WW, Burkowski FJ (2009) A constructive approach for discovering new drug leads: using a kernel methodology for the inverse-QSAR problem. J Cheminform 1:4

    Article  Google Scholar 

  14. Klopman G (1994) Artificial intelligence approach to structure-activity studies: computer automated structure evaluation of biological activity of organic molecules. J Am Chem Soc 106:7315–7321

    Article  Google Scholar 

  15. Raychaudhury C, Rizvi MIH, Pal D (2018) Combinatorial design of molecule using activity-linked substructural topological information as applied to antitubercular compounds. Curr Comput Aided Drug Des https://doi.org/10.2174/1573409914666180509152711

    Article  Google Scholar 

  16. Beyer T, Hedetniemi SM (1980) Constant time generation of rooted trees. SIAM J Comput 9:706–712

    Article  Google Scholar 

  17. Gibbs NE (1969) A cycle generation algorithm for finite undirected linear graphs. J ACM 16:564–568

    Article  Google Scholar 

  18. Klopman G, Raychaudhury C (1990) Vertex indexes of molecular graphs in structure-activity relationships: a study of the convulsant-anticonvulsant activity of barbiturates and the carcinogenicity of unsubstituted polycyclic aromatic hydrocarbons. J Chem Inf Comput Sci 30:12–19

    Article  CAS  Google Scholar 

  19. Raychaudhury C, Pal D (2012) Use of vertex index in structure-activity analysis and design of molecules. Curr Comput Aided Drug Des 8:128–134

    Article  CAS  Google Scholar 

  20. Raychaudhury C, Klopman G (1990) New vertex indices and their applications in evaluating antileukemic activity of 9-anilinoacridines and the activity of 2′, 3′-dideoxy-nuclosides against HIV. Bull Soc Chim Belg 99:255–264

    Article  CAS  Google Scholar 

  21. Raychaudhury C, Dey I, Bag P, Biswas G, Das B, Roy P, Banerjee A(1993) Use of a rule based graph-theoretical system in evaluating the activity of a class of nucleoside analogues against human immunodeficiency virus. Arzneim Forsch Drug Res 43:1122–1125

    Google Scholar 

  22. Prathipati P, Ma NL, Keller TH (2008) Global bayesian models for the prioritization of antitubercular agents. J Chem Inf Model 48:2362–2370

    Article  CAS  Google Scholar 

  23. GTB data set. http://pallab.cds.iisc.ac.in/gtb_data.mol

  24. Kandel DD, Raychaudhury C, Pal D (2014) Two new atom centered fragment descriptors and scoring function enhance classification of antibacterial activity. J Mol Model 20:2164

    Article  Google Scholar 

  25. Raychaudhury C, Kandel DD, Pal D (2014) Role of vertex index in substructure identification and activity prediction: a study on antitubercular activity of a series of acid alkyl ester derivatives. Croat Chem Acta 87:39–47

    Article  CAS  Google Scholar 

  26. Moss G (1999) Extension and revision of the von Baeyer system for naming polycyclic compounds (including bicyclic compounds). Pure Appl Chem 71:513–529

    Article  CAS  Google Scholar 

  27. Weininger D, Weininger A, Weininger JL (1989) SMILES. 2. Algorithm for generation of unique SMILES notation. J Chem Inf Comput Sci 29:97–101

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Debnath Pal .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rizvi, M.I.H., Raychaudhury, C., Pal, D. (2019). Combinatorial Drug Discovery from Activity-Related Substructure Identification. In: Mohan, C. (eds) Structural Bioinformatics: Applications in Preclinical Drug Discovery Process. Challenges and Advances in Computational Chemistry and Physics, vol 27. Springer, Cham. https://doi.org/10.1007/978-3-030-05282-9_4

Download citation

Publish with us

Policies and ethics